Related Experiment Video
Updated: May 10, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects
Wenzhao Li1, Shigehira Saji, Fumiaki Sato
1Department of Breast Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Abstract:
Matrix metalloproteinases (MMPs) are endopeptidases that are involved in extracellular matrix degradation. They are also implicated in a number of abnormal bioprocesses, such as tumor growth, invasion, and metastasis. Therefore, controlling MMP activities has generated considerable interest as a possible therapeutic target. The tissue inhibitors of metalloproteinases (TIMPs) are the major naturally occurring proteins that specifically inhibit MMPs and assist in maintaining the balance between extracellular matrix destruction and formation. However, TIMPs are probably not suitable for pharmacological applications due to their short half-lives in vivo. During the last few decades, synthetic MMP inhibitors (MMPIs) have undergone rapid clinical development in attempts to control MMP enzymatic activities in abnormal bioprocesses. Although studies with these agents have met with limited clinical success, the field of MMPIs is still expanding, and generation of highly effective and selective MMPIs might be a promising direction of this research area.
Insights
Matrix metalloproteinases (MMPs) are enzymes involved in tumor growth. While natural inhibitors (TIMPs) have limitations, synthetic MMP inhibitors (MMPIs) are being developed as potential therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Matrix metalloproteinases (MMPs) are enzymes crucial for extracellular matrix remodeling.
- Dysregulated MMP activity is linked to pathological processes including tumor growth, invasion, and metastasis.
- Targeting MMPs is a significant area of therapeutic interest.
Purpose of the Study:
- To review the role of MMPs in abnormal bioprocesses.
- To discuss the limitations of natural MMP inhibitors (TIMPs) for pharmacological use.
- To explore the development and potential of synthetic MMP inhibitors (MMPIs).
Main Methods:
- Literature review of MMPs, TIMPs, and synthetic MMPIs.
- Analysis of clinical development and success of MMPIs.
- Discussion of challenges and future directions in MMPI research.
Main Results:
- MMPs play a critical role in tumor progression.
- Natural inhibitors (TIMPs) have short in vivo half-lives, limiting their therapeutic utility.
- Synthetic MMPIs have shown limited clinical success to date, but research is ongoing.
Conclusions:
- Controlling MMP activity remains a key therapeutic strategy for various diseases.
- Development of effective and selective synthetic MMP inhibitors is a promising research avenue.
- Further research into MMPIs may yield successful therapeutic agents for cancer and other MMP-related disorders.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibitors of Viral Protein Synthesis
Mitogens and the Cell Cycle